Development of nanoparticles containing therapeutic candidates against SARS-CoV-2 intended for the pulmonary route
- Funded by ANR
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
ANRPrincipal Investigator
Bernard VERRIERResearch Location
FranceLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable